Syndax Pharmaceuticals, Inc. (SNDX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 1.82B |
| Enterprise Value | 2.03B |
| P/E Ratio | -4.02 |
| PEG Ratio | -0.09 |
| Price/Sales Ratio | 2.96 |
| Price/Book Ratio | -49.78 |
| Enterprise/Revenue | 4.53 |
| Enterprise/EBITDA | -10.99 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -0.72 |
| Operating Margin | -0.62 |
| Return On Assets | -0.3 |
| Return On Equity | -8.04 |
| Revenue | 172.35M |
| Revenue/Share | 3.22 |
| Gross Profit | 165.38M |
| EBITDA | -251.63M |
| Net Income | -285.42M |
| Diluted EPS | -3.29 |
| Total Cash | 427.1M |
| Total Cash/Share | 4.76 |
| Total Debt | 589.42M |
| Total Debt/Equity | -34.31 |
| Current Ratio | 4.69 |
| Book Value Per Share | -0.19 |
| 52-Week Change | -43.27 |
| 52-Week High | 25.59 |
| 52-Week Low | 9.15 |
| Moving Average 50 Days | 15.72 |
| Moving Average 200 Days | 19.83 |
| Average Volume | 2.45M |
| Shares Outstanding | 90.03M |
| % Held by Institutions | 122.39 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |